January 7. 2025, Newark, NJ — New Jersey Innovation Institute (NJII), an NJIT corporation, announced the launch of its fifth Division, Artificial Intelligence and Machine Learning, featuring New Jersey’s first and only AI Job Shop. …
Read more
Last month, NJII’s entrepreneurship team hosted an engaging virtual learning session as part of the New Jersey Innovation Fellows (NJIF) program, bringing together 30 first-time entrepreneurs to dive into the intricacies of fundraising. Moderated by …
Read more
Artificial intelligence training is becoming essential as its technologies continue to advance in today’s evolving workforce. According to a study by Gallup, “nearly seven in 10 employees say they never use AI, while one in …
Read more
2024 marked the official launch of NJII Healthcare’s Aging Collaborative, a new initiative that aims to build the future of the senior living industry and rethink service delivery for the aging population. The Aging Collaborative …
Read more
This year, the advanced manufacturing industry has been a beacon of innovation, adaptability, and resilience, and at the New Jersey Innovation Institute (NJII), we and our partners have been at the forefront of this transformation. …
Read more
As we look to the new year, the New Jersey Innovation Institute’s (NJII) Healthcare Division reflects back on the significant strides in advancing interoperability through healthcare technology, driving innovation, and fostering collaboration across the state’s …
Read moreAdministered by the New Jersey Department of Human Services (NJDHS), Division of Medical Assistance and Health Services (DMAHS), in collaboration with the Division of Mental Health and Addiction Services (DMHAS). Why Participate? Benefits Include: Who …
Read more
A study recently published by Apollo Research (https://www.apolloresearch.ai/research/scheming-reasoning-evaluations) that has gone viral reveals that several leading AI language models demonstrate the capability for “in-context scheming” – the ability to strategically pursue goals through deceptive means …
Read more
QuanBio is a groundbreaking company at the forefront of cardiovascular health innovation. Co-founded by Astrid Androsch and Dr. Vlad Friedman, a New York Presbyterian cardiologist, the company aims to address a significant gap in the …
Read more
December 2, 2024, Newark, NJ — New Jersey Innovation Institute (NJII), a subsidiary of New Jersey Institute of Technology (NJIT), is pleased to announce The Merck Digital Sciences Studio (MDS Studio) Cohort 3. NJII welcomed …
Read more